coronary lesions
Role of fractional flow reserve in guiding intervention for borderline coronary lesions
8
Long Coronary Lesions: Challenging Cases for Percutaneous Coronary Intervention
5
Novel drug-eluting stents in the treatment of de novo coronary lesions
16
LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography
7
The Effect of Sex and Anthropometry on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Complex Coronary Lesions
9
Classical determinants of coronary artery disease as predictors of complexity of coronary lesions, assessed with the SYNTAX score
8
Intravascular ultrasound-guided percutaneous coronary intervention in left main coronary bifurcation lesions: a review
11
Individuals with prediabetes identified by HbA1c undergoing coronary angiography have worse cardiometabolic profile than those identified by fasting glucose
7
Assessment of Intermediate Coronary Artery Lesion with Fractional Flow Reserve (FFR) versus Intravascular Ultrasound (IVUS)
8
Kawasaki Disease: Effect of Treatment on Coronary Artery Involvement
7
Analysis of the characteristics of coronary artery lesions in patients with obstructive sleep apnea-hypopnea syndrome and influencing factors
7
Sinus Node Ischemia—A Unique Presentation
6
Everolimus-eluting stents: update on current clinical studies
8
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
9
Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease
8
Stent Dislodgement During Coronary Angioplasty Complicated by Left Main Thrombosis: Application of VA-ECMO in The Catheterization Laboratory
5
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V<sup>®</sup>)
8
Fractional Flow Reserve Is Not Associated with Inflammatory Markers in Patients with Stable Coronary Artery Disease
9
Decreased type II/type I TGF beta receptor ratio in cells derived from human atherosclerotic lesions Conversion from an antiproliferative to profibrotic response to TGF beta1
10
Correlation of trans fatty acids with the severity of coronary artery disease lesions
13